BXRXQ (Baudax Bio) Common Stock: $0.12 Mil (As of Sep. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BXRXQ Baudax Bio Inc BXRXQ
12 GF Score
Price $0.00
View Full Analysis

What is Baudax Bio Common Stock?

Baudax Bio BXRXQ -99.00% 12 Common Stock is $0.12 Mil as of Sep. 2023. GuruFocus rates BXRXQ with a GF Score™ of 12/100.

Baudax Bio's quarterly common stock increased from Mar. 2023 ($0.03 Mil) to Jun. 2023 ($0.07 Mil) and increased from Jun. 2023 ($0.07 Mil) to Sep. 2023 ($0.12 Mil).

Baudax Bio's annual common stock declined from Dec. 2020 ($0.49 Mil) to Dec. 2021 ($0.00 Mil) but then increased from Dec. 2021 ($0.00 Mil) to Dec. 2022 ($0.02 Mil).

Baudax Bio Common Stock Historical Data

* Premium members only.

The historical data trend for Baudax Bio's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Baudax Bio Common Stock Chart

Baudax Bio Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Common Stock
Get a 7-Day Free Trial 0.00 0.09 0.49 0.00 0.02

Baudax Bio Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.20 0.02 0.03 0.07 0.12
BXRXQ
12GF Score
Baudax Bio Inc BXRXQ
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Baudax Bio Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $0.12 Mil mean?
Baudax Bio (BXRXQ) has a Common Stock of $0.12 Mil as of Sep. 2023. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Baudax Bio and its competitors.
Is Baudax Bio's Common Stock too high?
Baudax Bio's current Common Stock is $0.12 Mil. Overall, Baudax Bio has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Baudax Bio's Common Stock compare to INM and NBRVF?
Baudax Bio's Common Stock of $0.12 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Biotechnology company?
A good Common Stock depends on the Biotechnology industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Baudax Bio and its competitors. Baudax Bio's current Common Stock is $0.12 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Baudax Bio stock overvalued right now?
Baudax Bio (BXRXQ) has a current Common Stock of $0.12 Mil. The current Common Stock is $0.12 Mil. Baudax Bio's overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Baudax Bio (BXRXQ), the current Common Stock is $0.12 Mil as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Baudax Bio Business Description

Address 490 Lapp Road, Malvern, PA, USA, 19355
Baudax Bio Inc is a Pharmaceutical company. The company develops and commercialize products for hospital and related acute care settings. Its products are in pipeline which includes two novel neuromuscular blocking agents, or NMBAs and a dedicated reversal agent.
12GF Score

Get the complete analysis for BXRXQ

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price